O'Brien Wealth Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$537K Sell
4,286
-7
-0.2% -$892 0.07% 52
2025
Q3
$575K Buy
4,293
+3,506
+445% +$460K 0.08% 48
2025
Q2
$107K Buy
787
+43
+6% +$5.67K 0.02% 60
2025
Q1
$98.7K Buy
744
+10
+1% +$1.27K 0.02% 56
2024
Q4
$83K Hold
734
0.02% 57
2024
Q3
$83.7K Sell
734
-7
-0.9% -$768 0.02% 56
2024
Q2
$77K Sell
741
-17
-2% -$1.8K 0.02% 51
2024
Q1
$86.2K Hold
758
0.02% 53
2023
Q4
$83.4K Buy
+758
New +$75.7K 0.02% 53
2023
Q3
Sell
-747
Closed -$81.4K 57
2023
Q2
$81.4K Buy
+747
New +$79.6K 0.02% 51
2022
Q3
Sell
-1,341
Closed -$146K 58
2022
Q2
$146K Sell
1,341
-116
-8% -$13.2K 0.06% 56
2022
Q1
$156K Buy
1,457
+92
+7% +$11.4K 0.06% 46
2021
Q4
$176K Buy
+1,365
New +$175K 0.06% 43
2018
Q4
Sell
-734
Closed -$54K 45
2018
Q3
$54K Buy
+734
New +$48.2K 0.04% 70
2018
Q2
Sell
-734
Closed -$44K 93
2018
Q1
$44K Buy
+734
New +$44.2K 0.03% 64

Other funds holding ABT

O'Brien Wealth Partners's ABT Position: Q4 2025 in Review

O'Brien Wealth Partners reduced its Abbott (ABT) stake by 0.16% in Q4 2025, selling an estimated $892 and leaving 4,286 shares worth $537K. The position accounts for 0.07% of the portfolio, ranked #52.

O'Brien Wealth Partners first reported a position in ABT in Q1 2018 and has held it in 15 quarters since. The position peaked at $575K in Q3 2025. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • O'Brien Wealth Partners held 4,286 shares of Abbott worth $537K as of Q4 2025.
  • O'Brien Wealth Partners sold 7 Abbott shares in Q4 2025, an estimated $892.
  • Abbott made up 0.07% of O'Brien Wealth Partners's portfolio in Q4 2025, its #52 holding.
  • O'Brien Wealth Partners first reported a position in Abbott in Q1 2018 and has held it in 15 quarters since.
  • O'Brien Wealth Partners's Abbott position peaked at $575K in Q3 2025.
  • 3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on O'Brien Wealth Partners's 13F filing for Q4 2025, filed 22 Jan 2026.